Editorial: Cancer Treatment and Early Detection Targeting HER Receptors
Author:
Publisher
Frontiers Media SA
Subject
Biochemistry, Genetics and Molecular Biology (miscellaneous),Molecular Biology,Biochemistry
Reference5 articles.
1. EGFR-Expression in Primary Urinary Bladder Cancer and Corresponding Metastases and the Relation to HER2-Expression. On the Possibility to Target These Receptors with Radionuclides;Carlsson;Radiol. Oncol.,2015
2. A Review of HER4 (ErbB4) Kinase, its Impact on Cancer, and its Inhibitors;El-Gamal;Molecules,2021
3. The Epidermal Grwoth Factor-Like Domain of CD93 is a Potent Angiogenic Factor;Kao;PLoS One,2012
4. Assessing HER2 Gene Amplification as a Potential Target for Therapy in Invasive Urothelial Bladder Cancer with a Standardized Methodology: Results in 1005 Patients;Laé;Ann. Oncol.,2010
5. DNA-affibody Nanoparticles for Inhibiting Breast Cancer Cells Overexpressing HER2;Zhang;Chem. Commun.,2017
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Human Blood Serum Antagonizes Effects of EGFR/HER2-Targeted Drug Lapatinib on Squamous Carcinoma SK-BR-3 Cell Growth and Gene Expression;Биохимия;2024-09-14
2. Editorial: New strategies for reversing cancer therapy resistance;Frontiers in Pharmacology;2024-04-18
3. Human Blood Serum Counteracts EGFR/HER2-Targeted Drug Lapatinib Impact on Squamous Carcinoma SK-BR-3 Cell Growth and Gene Expression;Biochemistry (Moscow);2024-03
4. Editorial: Cancer treatment and early detection targeting HER receptors, Volume II;Frontiers in Molecular Biosciences;2023-06-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3